Abstract
Fine-needle aspiration cytology (FNAC) has been extensively used for many years in the diagnosis of breast lesions because it provides a rapid, accurate, and cost-effective evaluation. However, its use has gradually decreased because of the controversial rates of specimen inadequacy and suboptimal accuracy of diagnoses in inexperienced hands. In many countries, FNAC has been replaced by core needle biopsy (CNB), although often for the wrong reasons. Fortunately, in many places in the world, FNAC is still used as the first-line diagnosis of breast lesions in screening and symptomatic populations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kocjan G, Bourgain C, Fassina A, et al. The role of breast FNAC in diagnosis and clinical management: a survey of current practice. Cytopathology. 2008;19:271–8.
Tse GM, Poon CSP, Low BKB, et al. Fine needle aspiration cytology of granulomatous mastitis. J Clin Pathol. 2003;56:519–21.
Zhao C, Raza A, Martin SE, et al. Breast fine-needle aspiration samples reported as “proliferative breast lesion”: clinical utility of the subcategory “proliferative breast lesion with atypia”. Cancer. 2009;117:137–47.
Orell SR, Miliauskas J. Fine needle biopsy cytology of breast lesions: a review of interpretive difficulties. Adv Anat Pathol. 2005;12:233–45.
Field A, Mak A. The fine needle aspiration biopsy diagnostic criteria of proliferative breast lesions: a retrospective statistical analysis of criteria for papilloma and radial scar lesions. Diagn Cytopathol. 2007;35:386–97.
Krishnamurthy S, Ashfaq R, Shin HJ, et al. Distinction of phyllodes tumor from fibroadenoma: a reappraisal of an old problem. Cancer. 2000;90:342–9.
Kijima Y, Matsukita S, Yoshinaka H, et al. Adenoma of the nipple: report of a case. Breast Cancer. 2006;18:95–9.
Gupta RK, Dowle CS, Naran S, et al. Fine-needle aspiration cytodiagnosis of nipple adenoma (papillomatosis) in a man and woman. Diagn Cytopathol. 2004;31:432–3.
Pia-Foschini M, Reis-Filho JS, Eusebi V, et al. Salivary-gland like tumours of the breast: surgical and molecular pathology. J Clin Pathol. 2003;56:497–506.
Iyengar P, Cody III HS, Brogi E. Pleomorphic adenoma of the breast: case report and review of the literature. Diagn Cytopathol. 2005;33:416–20.
Hayes MM. Adenomyoepithelioma of the breast: a review stressing its propensity for malignant transformation. J Clin Pathol. 2011;64:477–84.
Iyengar P, Ali SZ, Brogi E. Fine-needle aspiration cytology of mammary adenomyoepithelioma: a study of 12 patients. Cancer. 2006;108:250–6.
Nayar R, De Frias DV, Bourtsos EP, et al. Cytologic differential diagnosis of papillary pattern in breast aspirates: correlation with histology. Ann Diagn Pathol. 2001;5:34–42.
Tse GM, Ma TKF, Lui PCW, et al. Fine needle aspiration cytology of papillary lesions of the breast: how accurate is the diagnosis? J Clin Pathol. 2008;61:945–9.
Pieterse AS, Mahar A, Orell S. Granular cell tumour: a pitfall in FNA cytology of breast lesions. Pathology. 2004;36:58–62.
Niveditha SR, Kusuma V, Krishnamurthy, et al. Cytomorphology of secretory hyperplastic (lactational) nodule breast. Cytopathology. 2006;17:153–61.
Ellis IO, Collins L, Ischihara S, et al. Invasive carcinoma of no special type. In: Lakhani SR, Ellis IO, Schnitt SJ, et al., editors. WHO classification of tumors of the breast. Lyon: IARC; 2012. p. 34–8.
Sneige N, Staerkel GA. Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ. Hum Pathol. 1994;25:485–92.
De la Torre M, Lindholm K, Lindgren A. Fine needle aspiration cytology of tubular breast carcinoma and radial scar. Acta Cytol. 1994;38:884–90.
Dufloth RM, Alves JM, Martins D, et al. Cytological criteria to predict basal phenotype of breast carcinomas. Diagn Cytopathol. 2009;37:809–14.
Morris KT, Pommier RF, Morris A, et al. Usefulness of the triple test score for palpable breast masses. Arch Surg. 2001;136:1008–12.
Tse GM, Tan PH. Diagnosing breast lesions by fine needle aspiration cytology or core biopsy: which is better? Breast Cancer Res Treat. 2010;123:1–8.
Rajesh L, Dey P, Joshi K. Fine needle aspiration cytology of lobular breast carcinoma. Comparison with other breast lesions. Acta Cytol. 2003;47:177–82.
Schmitt F, Sneige N, Lee A. Classification using needle-core biopsy and fine needle aspiration. In: Lakhani SR, Ellis IO, Schnitt SJ, et al., editors. WHO classification of tumors of the breast. Lyon: IARC; 2012. p. 26–7.
Stanley MW, Tani EM, Skoog L. Mucinous breast carcinoma and mixed mucinous-infiltrating ductal carcinoma: a comparative cytologic study. Diagn Cytopathol. 1989;5:134–8.
Reis-Filho JS, Milanezi F, Amendoeira I, et al. Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples. Cancer Cytopathol. 2003;99:172–9.
Gerhard R, Costa JL, Schmitt F. Benign and malignant apocrine lesions of the breast. Expert Rev Anticancer Ther. 2012;12:215–21.
Hammond ME, Hays DF, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med. 2010;134:e48–72.
Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25:118–45.
Allred C, Miller K, Viale G. Molecular testing for estrogen receptor, progesterone receptor, and HER2. In: Lakhani SR, Ellis IO, Schnitt SJ, et al., editors. WHO classification of tumors of the breast. Lyon: IARC; 2012. p. 22–3.
Skoog L, Tani E. Immunocytochemistry: an indispensable technique in routine cytology. Cytopathology. 2011;22:212–29.
Domanski AM, Monsef N, Domanski HA, Grabau D, Fernö M. Comparison of the oestrogen and progesterone receptor status in primary breast carcinomas as evaluated by immunohistochemistry and immunocytochemistry: a consecutive series of 267 patients. Cytopathology. 2013;24:21–5.
Schmitt FC, Bento MJ, Amendoeira I. Estimation of estrogen receptor content in fine-needle aspirates from breast cancer using the monoclonal antibody 1D5 and microwave oven processing: correlation with paraffin embedded and frozen sections determinations. Diagn Cytopathol. 1995;13:347–51.
Cano G, Milanezi F, Leitão D, et al. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2. Diagn Cytopathol. 2003;29:207–11.
Marinsek ZP, Nolde N, Kardum-Skelin I, et al. Multinational study of oestrogen and progesterone receptor immunocytochemistry on breast carcinoma fine needle aspirates. Cytopathology. 2013;24:7–20.
Beatty BG, Bryant R, Wang W, et al. HER-2/neu detection in fine-needle aspirates of breast cancer: fluorescence in situ hybridization and immunocytochemical analysis. Am J Clin Pathol. 2004;122:246–55.
Williams SL, Birdsong GG, Cohen C, et al. Immunohistochemical detection of estrogen and progesterone receptor and HER2 expression in breast carcinomas: comparison of cell block and tissue block preparations. Int J Clin Exp Pathol. 2009;2:476–80.
Kinsella MD, Birdsong GG, Siddiqui MT, et al. Immunohistochemical detection of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 in formalin-fixed breast carcinoma cell block preparations: correlation of results to corresponding tissue block (needle core and excision) samples. Diagn Cytopathol. 2013;41:192–8.
Shabaik A, Lin G, Peterson M, et al. Reliability of HER2/neu, estrogen receptor, and progesterone receptor testing by immunohistochemistry on cell block of FNA and serous effusions from patients with primary and metastatic breast carcinoma. Diagn Cytopathol. 2011;39:328–32.
Gorman BK, Kosarac O, Chakraborty S. Comparison of breast carcinoma prognostic/predictive biomarkers on cell blocks obtained by various methods: cellient, formalin and thrombin. Acta Cytol. 2012;56:289–96.
Bozzetti C, Nizzoli R, Guazzi A, et al. HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer. Ann Oncol. 2002;13:1398–403.
Vocaturo A, Novelli F, Benevolo M, et al. Chromogenic in situ hybridization to detect HER-2/neu gene amplification in histological and ThinPrep-processed breast cancer fine-needle aspirates: a sensitive and practical method in the trastuzumab era. Oncologist. 2006;11:878–86.
Reis-Filho JS, Pusztai L. Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet. 2011;378:1812–23.
Schmitt FC, Barroca H. Role of ancillary studies in fine-needle aspiration from selected tumors. Cancer Cytopathol. 2011;120:145–60.
Annaratone L, Marchio C, Renzulli T, et al. High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer. Transl Oncol. 2012;10:1–10.
Eloy C, Amendoeira I, Schmitt FC. Fine-needle aspiration as an alternative method for frozen tissue banking of breast cancer. Diagn Cytopathol. 2009;37:76–7.
Tabchy A, Valero V, Vidaurre T, et al. Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer. Clin Cancer Res. 2010;16:5351–61.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Schmitt, F., Gerhard, R., Stanley, D.E., Domanski, H.A. (2014). Breast. In: Domanski, H. (eds) Atlas of Fine Needle Aspiration Cytology. Springer, London. https://doi.org/10.1007/978-1-4471-2446-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2446-7_3
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2445-0
Online ISBN: 978-1-4471-2446-7
eBook Packages: MedicineMedicine (R0)